Corticosteroids for viral myocarditis

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2006, Pages

  Chen, Huai Sheng ^a   Liu, J ^b   Yang, M ^b  

^a SHENZHEN PEOPLE'S HOSPITAL   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; BETAMETHASONE; BUDESONIDE; CORTICOSTEROID; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; MINERALOCORTICOID; PLACEBO; PREDNISONE;

BIOSIS; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; EMBASE; HUMAN; MEDLINE; META ANALYSIS; METHODOLOGY; REVIEW; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; VIRUS MYOCARDITIS;

EID: 42749105499     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004471.pub2     Document Type: Review

References (35)

1. * Camargo PR, Snitcowsky R, da Luz PL, Mazzieri R, Higuchi ML, Rati M, et al. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatric Cardiology 1995;16(2):61-8.
2. Hufnagel G, Pankuweit S, Richter A, Schonian U, Maisch B. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz 2000;25(3):279-285.
3. * Maisch B, Hufnagel G, Schonian U, Hengstenberg C. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID). European Heart Journal 1995;16 Suppl O:173-175.
4. * Kong Qing-fu, Song Shu-zhi, Xie Xue-ying, Zhang Xin-hua, Yue Ge-jie, Chen Zhao-li. Clinical study on therapeutic effects of treatment according to syndrome differentiation of Traditional Chinese Medicine combined with captopril on severe viral myocarditis complicated heart failure. Zhongguo Zhong Xi Yi Jie He Za Zhi 2001;21(7):513-515.
5. * Latham RD, Mulrow JP, Virmani R, Robinowitz M, Moody JM. Recently diagnosed idiopathic dilated cardiomyopathy: incidence of myocarditis and efficacy of prednisone therapy. American Heart Journal 1989;117(4):876-882.
6. * Liu Dezue. Observation of integrated Chinese traditional and Western medicine on acute viral myocarditis. Xian Dai Zhong Xi Yi Jie He Za Zhi 2002;11(6):481-2.
7. * Liu Dezue, Yang Lei, Jiang Haixia. Clinical search of sheng mai injection combined with corticosteroids for acute viral myocarditis in children. Journal of Sichuan of Traditional Chinese Medicine 2003;21(12): 59-60.
8. Maisch B, Herzum M, Hufnagel G, Hengstenberg C, Schonian U, Bittinger A, et al. Immunosuppressive treatment in auto-reactive myocarditis results from a placebo-controlled trial. Journal of American College of Cardiology. 1995, issue Special Issue:325A.
9. * Maisch B, Herzum M, Hufnagel G, Hengstenberg C, Schonian U, Bittinger A, et al. Immunosuppressive treatment in auto-reactive myocarditis results from a placebo-controlled trial. Journal of the American College of Cardiology 1993;21(2 Suppl A):21A.
10. * Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. New England Journal of Medicine 1995;333(5):269-275.
11. * Sun Dabao. Corticosteroids treatment effects in 36 cases diagnosed with viral myocarditis with ventricle premature beats. Journal of Zhenjiang Medical College 1999;9(2):211.
12. * Wu Yao-zhang, Chen Bing-Wang. Observation on curative effects of astragalus injection combined with glucocorticoid on acutely severe viral myocarditis. Zhongguo Zhong Xi Yi Jie He Ji Jiu Za Zhi 1999;6 (8):350-352.
13. Batra AS, Lewis AB. Acute myocarditis. Currence Opinion in Pediatrics 2001;13(3):234-9.
14. Brown CA, O'Connell JB. Myocarditis and idiopathic dilated cardiomyopathy. American Journal of Medicine 1995;99(3):309-14.
15. Brown CA, O'Connell JB. Implications of the Myocarditis Treatment Trial for clinical practice. Current Opinion in Cardiology 1996;11(3): 332-6.
16. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. British Medical Journal 1994;309:1286-9.
17. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple graphical test. British Medical Journal 1997;315:629-34.
18. Frustaci A, Calabrese F, Chimenti C, Pieroni M, Thiene G, Maseri A. Lone hepatitis C virus myocarditis responsive to immunosuppressive therapy. Chest 2002;122(4):1348-1356.
19. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic prole of responders versus nonresponders. Circulation 2003;107(6):857-863.
20. Garg A, Shiau J, Guyatt G. The ineffectiveness of immunosuppressive therapy in lymphocytic myocarditis: an overview. Annals of Internal Medicine 1998;129(4):317-22.
21. Gluud C. Alcoholic hepatitis: no glucocorticosteroids?. In: LeuschnerOFW, DancygierJ, DancygierH editor(s). Steatohepatitis : NASH and ASH proceedings of Falk Symposium 121. London: Kluwer Academic, 2001:322-42.
22. Hobbs RE, Pelegrin D, Ratliff NB, Bott-Silverman C, Rincon G, Sterba R, et al. Lymphocytic myocarditis and dilated cardiomyopathy: treatment with immunosuppressive agents. Cleveland Clinic Journal of Medicine 1989;56(6):628-635.
23. International Conference on Harmonisation Expert Working Group. Code of Federal Regulations & International Conference on Harmonisation Guidelines. Philadelphia: Barnett International/PAREXEL, 1997.
24. Kearney MT, Cotton JM, Richardson PJ, Shah AM. Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management. Postgraduate Medical Journal 2001;77(903):4-10.
25. Lefebvre C, Mcdonald S. Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE. Paper presented at the Fourth International Cochrane Colloquium. Adelaide, Australia: 20-24 Oct 1996.
26. Liu P, Martimo T, Opavsky MA, Penninger J. Viral myocarditis: balance between viral infection and immune response. Canadian Journal of Cardiology 1996;12(10):935-43.
27. Liu JP, Yang M, Du XM. Herbal medicines for viral myocarditis. In: The Cochrane Database of Systematic Reviews, 3, 2004.
28. Maisch B, Schonian U, Hengstenberg C, Herzum M, Hufnagel G, Bethge C, et al. Immunosuppressive treatment in autoreactive myocarditis-results from a controlled trial. Postgraduate Medical Journal 1994;70(Suppl 1):S29-34.
29. Mason JW. Immunopathogenesis and treatment of myocarditis: the United States Myocarditis Treatment Trial. Journal of Cardic Failure 1996;2(4 Suppl):S173-7.
30. McNamara DM. Diagnosis and medical treatment of inflammatory cardiomyopathy. In: Eric J.Topol editor(s). Textbook of Cardiovascular Medicine. 2nd Edition. Shangdong, China: Lippincott Williams & Wilkins; Shangdong Science & Technology Press, 2002:1899-1913.
31. National Special Commitee of Myocarditis and Myopathology. Summary of National Myocarditis and Cardiomyopathical Discussion Meeting. Journal of Clinical Cardiology 1995;11(6):324-6.
32. Olinde KD, O'Connell JB. Inflammatory heart disease: Pathogenesis, clinical manifestations, and treatment of myocarditis. Annual Review of Medicine 1994;45:481-90.
33. Schulz KF, Chalmers I, Hayes R, Altman D. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
34. Vickers A, Goyal N, Harland R, Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Controlled Clinical Trials 1998;19:159-66.
35. Commitee of editors of Zhong Hua Nei Ke Za Zhi. Summary of National Myocarditis and Cardiomyopathical Discussion Meeting. Zhong Hua Nei Ke Za Zhi 1987;26(10):597-601.